Cardiology Letters 2022, 31(5):298-32
Primary hyperaldosteronism - an often underestimated reason for arterial hypertension
- 1. interná klinika UPJŠ LF a UNLP Košice, Slovenská republika
Primary hyperaldosteronism (PH), i.e. Conn syndrome, is considered the most common cause of endocrine hypertension with the prevalence of 5-10% in the general population of hypertensive subjects and 20-30% in patients with resistant and severe hypertension. Therefore its systematic screening among hypertonics is very important. Screening of PH should be a part of differential diagnosis in selected groups of hypertonics, especially those with resistant or severe diastolic hypertension. Because long term aldosterone overproduction may cause severe organ complications such as cardiovascular and cerebrovascular events and renal impairment, it is necessary to recognize and to treat this syndrome very early. This review is focused on clinical management of patients with PH based on current guidelines.
Keywords: primary hyperaldosteronism; aldosterone-renin ratio; screening; diagnosis; treatment
Published: May 1, 2022 Show citation
References
- Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens. 2020 Oct;38:1919-1928.
Go to original source... - Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021Dec;9:876-892.
Go to original source... - Funder JW. Primary Aldosteronism. Hypertension. 2019 Sep;74:458-466.
Go to original source... - Omata K, Tomlins SA, Rainey WE. Aldosterone-Producing Cell Clusters in Normal and Pathological States. Horm Metab Res. 2017 Dec;49:951-956.
Go to original source... - Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016 May;101:1889-1916.
Go to original source... - Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol. 2017 Apr 11;69:1811-1820.
Go to original source... - Widimský J, Bruthans J, Wohlfahrt P, Krajčoviechová A, Šulc P, Linhart A, et al. Primary aldosteronism in a general population sample. The Czech post-MONICA study. Blood Press. 2020 Jun;29:191-198.
Go to original source... - Baudrand R, Guarda FJ, Fardella C, Hundemer G, Brown J, Williams G, Vaidya A. Continuum of Renin-Independent Aldosteronism in Normotension. Hypertension. 2017 May;69:950-956.
Go to original source... - Gurgenci T, Geraghty S, Wolley M, Yang J. Screening for primary aldosteronism: How to adjust existing antihypertensive medications to avoid diagnostic errors. Aust J Gen Pract. 2020 Mar;49:127-131.
Go to original source... - O'Shea PM, Griffin TP, Denieffe S, Fitzgibbon MC. The aldosterone to renin ratio in the diagnosis of primary aldosteronism: Promises and challenges. Int J Clin Pract. 2019 Jul;73:e13353. doi: 10.1111/ijcp.13353.
Go to original source... - Eugenio Russmann ML, Delfino L, Fierro F, Santoro S, Peréz M, Caruso G, et al. Primary aldosteronism: Aldosterone/renin ratio cut-off points. Endocrinol Diabetes Nutr (Engl Ed). 2019 Jun-Jul;66:361-367.
Go to original source... - Cyrańska-Chyrek E, Grzymisławska M, Ruchała M. Diagnostic pitfalls of adrenal incidentaloma. Endokrynol Pol. 2017;68:360377.
Go to original source... - Hundemer GL, Vaidya A. Primary Aldosteronism Diagnosis and Management: A Clinical Approach. Endocrinol Metab Clin North Am. 2019 Dec;48(4):681-700.
Go to original source... - Lazúrová I. Primárny hyperaldosteronizmus. In: Lazúrová I, Payer J. Štandardné diagnostické a terapeutické postupy v endokrinológii. Košice: Vienala; 2013:169-177.
- Stowasser M, Ahmed AH, Cowley D, Wolley M, Guo Z, McWhinney BC, et al. Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism. J Clin Endocrinol Metab. 2018 Nov 1;103:4113-4124.
Go to original source... - Song Y, Yang S, He W, Hu J, Cheng Q, Wang Y, et al. Chongqing Primary Aldosteronism Study (CONPASS) Group†. Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study. Hypertension. 2018 Jan;71:118-124.
Go to original source... - Kempers MJ, Lenders JW, van Outheusden L, van der Wilt GJ, Schultze Kool LJ, et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009 Sep 1;151:329337.
Go to original source... - Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Primary Aldosteronism Surgery Outcome (PASO) investigators. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017 Sep;5:689-699.
Go to original source... - Rossi GP. Primary Aldosteronism: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 Dec 3;74:2799-2811.
Go to original source...

